Trends in Lung Cancer Presentation and Survival in the Era of Screening

Early-stage diagnoses and all-cause survival accelerated in 2014, after CT screening was recommended for high-risk patients.

In December 2013, the U.S. Preventive Services Task Force recommended low-dose computed tomography (CT) screening for lung cancer in high-risk individuals (NEJM JW Gen Med Feb 15 2014 and Ann Intern Med 2014; 160:330). Randomized trials demonstrated that malignancies were diagnosed at earlier stages and survival improved in screened groups, but these effects have not been demonstrated in real-world populations.

Using U.S. national oncology databases, investigators identified >750,000 patients who received diagnoses of non–small-cell lung cancer (NSCLC) between 2010 and 2018. Among these patients, the percentage who received diagnoses of stage I NSCLC and median all-cause survival increased significantly more rapidly from 2014 to 2018 than fr…

Reviewing Author

Bruce Soloway, MD

Disclosures

Editorial BoardsNew RoAR News (http://www.newroarnews.org)

Bruce Soloway, MD

Disclosures

Editorial BoardsNew RoAR News (http://www.newroarnews.org)

Trends in Lung Cancer Presentation and Survival in the Era of Screening

Topics

Reviewing Author